ClinicalTrials.Veeva

Menu

"UroMonitor Trial" in Spinal Cord Injury.

University of British Columbia logo

University of British Columbia

Status

Withdrawn

Conditions

Spinal Cord Injuries

Treatments

Device: UroMonitor System

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT04800523
H20-01267

Details and patient eligibility

About

This study aims to determine if a non-functioning UroMonitor device can be safely inserted, monitored, and removed in patients with SCI.

Full description

This prospective, observational study will be conducted with 10 patients with chronic thoracolumbar SCI who are already undergoing routine UDS studies as part of their care. Following their routine UDS, a non-functioning UroMonitor device will be inserted and removed after 3 hours. Participants' symptoms will be monitored after the UroMonitor is inserted, following the 3 hour monitoring period, and again after UroMonitor removal. A second cystoscopy will be conducted for research purposes after removal to examine the urethra and bladder for any irritation or trauma. During insertion and removal, the urologist will document the time required for insertion and any difficulties encountered

Sex

All

Ages

17 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Cervical or Thoracolumbar (T2-L1 spinal level) spinal cord injury with AIS A, B, C, or D severities of injury.
  2. Age 17-75.
  3. At least 1 year post-injury.
  4. At least one prior urodynamics study in the past 12 months that has objectively documented abnormalities on bladder function consistent with an upper motor neuro lesion.
  5. History of neurogenic bladder symptoms requiring some form of intervention (e.g. clean intermittent catheterization, condom catheter)

Exclusion criteria

  1. Lumbar injuries (L2-S1 spinal level) where the injury is primarily to the cauda equina and not to spinal cord.
  2. History of autonomic dysreflexia (such individuals are excluded to minimize the chance of inducing autonomic dysreflexia with device insertion).
  3. Active urinary tract infection.
  4. Past urethral or bladder reconstruction surgery

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Arm 1 - Non-functional Device
Experimental group
Description:
a non-functional UroMonitor will be inserted by urologist.
Treatment:
Device: UroMonitor System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems